Simple Summary The treatment of peri-hilar (h-CCA) and intrahepatic (i-CCA)
cholangiocarcinoma is an evolving field in hepato-pancreato-biliary surgery. Continuous …

Background and Objectives: Liver transplantation (LT) is the best strategy for curing several
primary and secondary hepatic malignancies. In recent years, growing interest has been …

Cholangiocarcinoma is a lethal malignancy of the biliary epithelium that can arise anywhere
along the biliary tract. Surgical resection confers the greatest likelihood of long‐term …

Background Hepatectomy with vascular resection (VR) for perihilar cholangiocarcinoma
(PHCC) is a challenging procedure. However, only a few reports on this procedure have …

Background Perihilar cholangiocarcinoma (phCCC) is a dismal malignancy. There is no
consensus regarding the best treatment for patients with unresectable phCCC. The present …

Patients with hilar cholangiocarcinoma (hCCA) have advanced disease at presentation and
therefore curative treatment options are limited. Liver transplantation (LT), in the case of …

Background Achieving a better prognosis for patients and reducing the risk of complications
are primary considerations in surgical decisions for hilar cholangiocarcinoma. Methods A …

It is difficult to directly obtain pathological diagnosis of perihilar cholangiocarcinoma (pCCA).
Analysis of bile in the pCCA microenvironment, based on metabolomics and statistical …

Background Preoperative serum carbohydrate antigen 125 (CA125) is used to judge the
diagnosis and prognosis of various tumors. However, the relationship between preoperative …

Cholangiocarcinoma (CCA) is an epithelial malignancy of the bile tract that has a poor
prognosis and lacks effective treatments. The first-line systemic therapy for CCA patients is …